Response to "Medical Statistics Unlock the Gateway to Further Research: Using Deep Learning to Predict CDKN2A/B Homozygous Deletion in Isocitrate Dehydrogenase-Mutant Astrocytoma".
作者信息
Park Yae Won, Han Kyunghwa, Kim Se Hoon
机构信息
Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea.
出版信息
Korean J Radiol. 2023 Dec;24(12):1306-1308. doi: 10.3348/kjr.2023.0940.
Abstract
摘要
相似文献
1
Response to "Medical Statistics Unlock the Gateway to Further Research: Using Deep Learning to Predict CDKN2A/B Homozygous Deletion in Isocitrate Dehydrogenase-Mutant Astrocytoma".
Korean J Radiol. 2023 Dec;24(12):1306-1308. doi: 10.3348/kjr.2023.0940.
2
Medical Statistics Unlock the Gateway to Further Research: Using Deep Learning to Predict CDKN2A/B Homozygous Deletion in Isocitrate Dehydrogenase-Mutant Astrocytoma.
Korean J Radiol. 2023 Dec;24(12):1303-1305. doi: 10.3348/kjr.2023.0925.
3
A novel MRI-based deep learning networks combined with attention mechanism for predicting CDKN2A/B homozygous deletion status in IDH-mutant astrocytoma.
Eur Radiol. 2024 Jan;34(1):391-399. doi: 10.1007/s00330-023-09944-y. Epub 2023 Aug 8.
4
Preoperative Discrimination of CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytoma: A Deep Learning-Based Radiomics Model Using MRI.
J Magn Reson Imaging. 2024 May;59(5):1655-1664. doi: 10.1002/jmri.28945. Epub 2023 Aug 9.
5
Editorial for "Preoperative Discrimination of CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytoma: A Deep Learning-Based Radiomics Model Using MRI".
J Magn Reson Imaging. 2024 May;59(5):1665-1666. doi: 10.1002/jmri.28846. Epub 2023 Jun 12.
6
Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study.
Korean J Radiol. 2023 Feb;24(2):133-144. doi: 10.3348/kjr.2022.0732.
7
Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma.
Neuro Oncol. 2023 Jan 5;25(1):28-36. doi: 10.1093/neuonc/noac205.
8
Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033.
Neuro Oncol. 2023 Aug 3;25(8):1443-1449. doi: 10.1093/neuonc/noac282.
9
[Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for CDKN2A homozygous deletion in brain tumors].
Zhonghua Bing Li Xue Za Zhi. 2024 May 8;53(5):439-445. doi: 10.3760/cma.j.cn112151-20230815-00069.
10
A novel grading system combining histological grade and CDKN2A homozygous and hemizygous deletion to predict prognosis in IDH-mutant astrocytoma.
J Neuropathol Exp Neurol. 2024 Jan 19;83(2):125-130. doi: 10.1093/jnen/nlad112.
本文引用的文献
1
Medical Statistics Unlock the Gateway to Further Research: Using Deep Learning to Predict CDKN2A/B Homozygous Deletion in Isocitrate Dehydrogenase-Mutant Astrocytoma.
Korean J Radiol. 2023 Dec;24(12):1303-1305. doi: 10.3348/kjr.2023.0925.
2
Preoperative Discrimination of CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytoma: A Deep Learning-Based Radiomics Model Using MRI.
J Magn Reson Imaging. 2024 May;59(5):1655-1664. doi: 10.1002/jmri.28945. Epub 2023 Aug 9.
3
A novel MRI-based deep learning networks combined with attention mechanism for predicting CDKN2A/B homozygous deletion status in IDH-mutant astrocytoma.
Eur Radiol. 2024 Jan;34(1):391-399. doi: 10.1007/s00330-023-09944-y. Epub 2023 Aug 8.
4
Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study.
Korean J Radiol. 2023 Feb;24(2):133-144. doi: 10.3348/kjr.2022.0732.
5
Radiomics machine learning study with a small sample size: Single random training-test set split may lead to unreliable results.
PLoS One. 2021 Aug 12;16(8):e0256152. doi: 10.1371/journal.pone.0256152. eCollection 2021.
6
Key Principles of Clinical Validation, Device Approval, and Insurance Coverage Decisions of Artificial Intelligence.
Korean J Radiol. 2021 Mar;22(3):442-453. doi: 10.3348/kjr.2021.0048.
7
The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature.
J Neurooncol. 2020 Jun;148(2):221-229. doi: 10.1007/s11060-020-03528-2. Epub 2020 May 8.
8
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
Neuro Oncol. 2019 Dec 17;21(12):1519-1528. doi: 10.1093/neuonc/noz124.
9
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models.
J Clin Epidemiol. 2019 Jun;110:12-22. doi: 10.1016/j.jclinepi.2019.02.004. Epub 2019 Feb 11.
10
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.
Acta Neuropathol. 2018 Jul;136(1):153-166. doi: 10.1007/s00401-018-1849-4. Epub 2018 Apr 23.
Zotero 插件